Merck
CN

206229

Sigma-Aldrich

氯化钌 (III) 水合物

ReagentPlus®

登录查看公司和协议定价

别名:
三氯化钌
线性分子式:
RuCl3 · xH2O
CAS号:
分子量:
207.43 (anhydrous basis)
EC 号:
MDL编号:
PubChem化学物质编号:
NACRES:
NA.23

产品线

ReagentPlus®

形式

powder and chunks

组成

Degree of hydration, ≤1
Ruthenium content, 40.00-49.00%

反应适用性

reagent type: catalyst
core: ruthenium

杂质

≤0.1% Insoluble matter (C=1%, 25% HCl)

SMILES字符串

O.Cl[Ru](Cl)Cl

InChI

1S/3ClH.H2O.Ru/h3*1H;1H2;/q;;;;+3/p-3

InChI key

BIXNGBXQRRXPLM-UHFFFAOYSA-K

正在寻找类似产品? Visit 产品对比指南

一般描述

可溶型

应用

它被用于制备纳米颗粒钌-氢氧化铝氧化物催化剂,使芳甲基醇有效脱氢生成相应的醛。该产物可催化由伯芳香胺和三烯丙基胺合成2-乙基-3-甲基喹啉。使用 RhCl3 在二氧化钛纳米管上沉积制备的钌水合氧化物,可用作分子氧选择性氧化醇的催化体系。

法律信息

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany

警示用语:

Danger

危险声明

危险分类

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1B

储存分类代码

8A - Combustible, corrosive hazardous materials

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

为方便起见,与您过往购买产品相关的文件已保存在文档库中。

访问文档库

难以找到您所需的产品或批次号码?

在网站页面上,产品编号会附带包装尺寸/数量一起显示(例如:T1503-25G)。请确保 在“产品编号”字段中仅输入产品编号 (示例: T1503).

示例

T1503
货号
-
25G
包装规格/数量

其它示例:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

输入内容 1.000309185)

遇到问题?欢迎随时联系我们技术服务 寻求帮助

批号可以在产品标签上"批“ (Lot或Batch)字后面找到。

Aldrich 产品

  • 如果您查询到的批号为 TO09019TO 等,请输入去除前两位字母的批号:09019TO。

  • 如果您查询到的批号含有填充代码(例如05427ES-021),请输入去除填充代码-021的批号:05427ES。

  • 如果您查询到的批号含有填充代码(例如 STBB0728K9),请输入去除填充代码K9的批号:STBB0728。

未找到您寻找的产品?

部分情况下,可能未在线提供COA。如果搜索不到COA,可在线索取。

索取COA

TiO 2 nanotube-supported ruthenium (III) hydrated oxide: A highly active catalyst for selective oxidation of alcohols by oxygen.
Bavykin DV, et al.
J. Catal., 235(1), 10-17 (2005)
Cho, C.S. et al.
Tetrahedron Letters, 40, 1499-1499 (1999)
Won-Hee Kim et al.
Organic letters, 8(12), 2543-2545 (2006-06-02)
An efficient oxidant-free oxidation for a wide range of alcohols was achieved by a recyclable ruthenium catalyst. The catalyst was prepared from readily available reagents by a one-pot synthesis through nanoparticle generation and gelation. [structure: see text]
Yao Zhang et al.
European journal of medicinal chemistry, 86, 449-455 (2014-09-10)
Ruthenium-based anticancer complexes have become increasingly popular for study over the last two decades. Although ruthenium complexes are currently being investigated in clinical trials, there are still some difficulties with their delivery and associated side effects. Human serum albumin (HSA)-based
Huaiyi Huang et al.
Dalton transactions (Cambridge, England : 2003), 44(35), 15602-15610 (2015-08-08)
Ruthenium complexes have been considered as promising substitutes for cisplatin in cancer chemotherapy. However, novel ruthenium-based therapies are faced with some limitations, such as unimpressive cytotoxicity toward solid tumors. Herein, we designed and synthesized phenyl-substituted terpyridyl ruthenium(ii) complexes ([Ru(tpy)(bpy)Cl](+) (Ru1)

商品

Hydrogen is one of the most important resources in providing food, fuel, and chemical products for our everyday life. Sustainable catalytic hydrogen production from bioethanol has gained significant attention in recent years due to globally diminishing fossil fuel supplies, which have necessitated the search for new chemical feedstocks.

The prevailing strategies for heat and electric-power production that rely on fossil and fission fuels are having a negative impact on the environment and on our living conditions.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门